Canine hip dysplasia (CHD) is one of the most common hereditary orthopaedic conditions in dogs, driven by abnormal hip joint laxity and the secondary osteoarthritis that develops as a result. It is most prevalent in medium to large breeds — German Shepherd Dogs, Labrador Retrievers, Golden Retrievers, and Rottweilers among the most commonly affected — though it can occur in any breed. The Orthopedic Foundation for Animals (OFA) reports that up to 76% of severely dysplastic dogs with arthritis secondary to hip dysplasia are able to function and live comfortably with appropriate medical management. That figure carries a critical qualifier: “appropriate medical management” requires consistent follow-up, weight monitoring, pain assessment, and medication adjustment over the dog’s lifetime.
Why hip dysplasia follow-up is a long-term pain management programme
Hip dysplasia is a developmental abnormality, not a disease episode — which means the follow-up model is not “monitor until resolved” but “monitor and adjust for life.” The severity of clinical signs does not reliably correlate with radiographic findings. OFA states explicitly that some dogs with severe radiographic hip changes show no lameness, while others with minimal X-ray changes are severely affected. This means clinical signs and owner observations are the primary monitoring tool — not imaging alone.
The weight management element is often the most high-impact and least-maintained intervention. Research has shown that a 10% reduction in body weight in overweight dysplastic dogs is associated with meaningful symptom relief, and that weight loss on average delays the need for surgical intervention by three years. Owners who don’t maintain their dog at an appropriate weight undermine every other management intervention. A follow-up call that includes a direct weight question — and a reminder of the target weight — keeps this variable in focus between appointments.
NSAIDs are the primary pharmacological management tool, and their use requires periodic blood monitoring for renal and hepatic function. Dogs on long-term NSAID therapy for hip dysplasia need bloods every 6 months — a monitoring schedule that is easily deferred without a proactive reminder. The risk is that NSAID-related renal or GI complications develop in a dog that has been on medication for months without blood work review.
PetMD recommends that dogs with hip dysplasia are seen every six months — but the between-appointment period is where owner compliance with weight management, exercise restriction, and medication consistency determines the clinical outcome.
The hip dysplasia follow-up timeline
| Timepoint | What to check | Red flags |
|---|---|---|
| 2–4 weeks post-diagnosis / treatment change | Initial response to NSAIDs, any GI side effects, weight at target range, exercise modification in place, owner understanding of lifelong management | No improvement in lameness after 4 weeks on appropriate NSAIDs — reassess dose or drug choice; GI side effects |
| 6–8 weeks | Lameness score improvement, weight stable or reducing toward target, owner adherence to exercise modification (controlled, low-impact only), supplementation in place | Owner allowing free running or ball chasing — direct activity driver of symptom worsening and OA progression |
| Every 6 months (stable) | Blood work (renal, hepatic, CBC), weight, lameness assessment, medication review, pain score | Deteriorating bloods on NSAID therapy — dose reduction or switch; significant weight gain; worsening lameness despite management |
| As needed | Acute flare assessment — pain significantly worse after activity, slipping on hard floors, reluctance to rise | Acute significant worsening — assess for concurrent disease, reconsider surgical options |
What to ask owners during hip dysplasia follow-up
- How is [dog name]‘s lameness — is she walking more freely, or about the same as before treatment started?
- Have you noticed any stiffness after rest — does she loosen up once she’s been moving for a few minutes?
- Is she maintaining a healthy weight — and has she been on her reduced calorie diet consistently?
- Have you been keeping exercise to controlled leash walks only — no running, jumping, or ball chasing?
- Are you giving the NSAIDs consistently at the same time each day?
- Have you noticed any changes in appetite, drinking, or vomiting that might suggest the medication is upsetting her stomach?
- Are you giving the joint supplements as recommended?
- Has she been doing any physiotherapy or hydrotherapy exercises, and how is she tolerating those?
- On cold or damp days — do you notice her stiffness is worse?
- Do you have your 6-month blood work and check-up booked?
Common hip dysplasia follow-up mistakes clinics make
Not quantifying weight management goals. “She should lose a bit of weight” is insufficient. Owners need to know the current weight, the target weight, the caloric target for the prescription diet, and a timeline for reassessment. A follow-up call at 6 weeks that asks about current weight and food compliance — not just “how is she doing?” — keeps the weight management programme active between appointments.
Not addressing ball-chasing and running. Many owners of working and sporting breeds find the exercise restriction the hardest element to maintain — particularly when the dog appears to want to run. A follow-up call that specifically asks “has she been running or chasing a ball at all?” is the only mechanism for catching this. Owners who volunteer this information often add “but only for a few minutes” — which, in a dysplastic dog with active OA, is enough to trigger a significant flare.
Skipping blood monitoring reminders. Dogs on long-term NSAID therapy need renal and hepatic monitoring every 6 months. Without a proactive reminder system, this is the appointment most likely to be deferred by both clinic and owner. A follow-up call at the 5-month mark — “your blood work appointment for [dog] is coming up next month — shall we book it?” — keeps the monitoring schedule intact.
How to automate hip dysplasia follow-up without adding to your team’s workload
Nidana Loop schedules a 4-week NSAID response check call and a 6-week weight and activity compliance call automatically from the hip dysplasia discharge note. For stable patients on long-term management, Loop schedules a 5-month blood work reminder. The calls ask specifically about lameness, weight, activity compliance, and GI side effects — the owner-side data that complements the clinic’s physical examination and blood results.
See how Loop handles hip dysplasia follow-up calls → Book a 20-minute demo
Related: Arthritis follow-up in dogs and cats · TPLO recovery follow-up · IVDD follow-up